この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
規制と法律 · 2016/9/261 分で読めます
Prospective Grant of Exclusive Patent License: Development of Adeno-Associated Virus-Based Vectors for the Treatment of Menkes Disease and Related Copper Transport Disorders
ローカル自動翻訳 · 情報源の原言語
概要
The Eunice Kennedy Shriver National Institute of Child Health and Human Development, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Commercialization Patent License to practice the inventions embodied in the U.S. Patents and Patent Applications listed in the Supplementary Information section of this notice to Cyprium Therapeutics, Inc. ("Cyprium") located in New York, NY, USA.
情報源の原言語: Federal Register — All Documents原文の発表を開く →